Literature DB >> 23503668

[Bleeding origin, patient-related risk factors, and prognostic indicators in patients with acute gastrointestinal hemorrhages requiring intensive care treatment. A retrospective analysis from 1999 to 2010].

A Koch1, L Buendgens, H Dückers, J Bruensing, M Matthes, J Kunze, H H Lutz, T Luedde, J J W Tischendorf, C Trautwein, F Tacke.   

Abstract

BACKGROUND: Gastrointestinal bleeding (GIB) is a common problem in elderly patients involving severe comorbidities and concomitant antiplatelet or anticoagulatory therapy. The risk factors and prognostic indicators of patients with severe GIB requiring intensive care medical treatment have not been well evaluated.
METHODS: A retrospective analysis of 7,376 patients from the medical intensive care unit (ICU) at the University Hospital Aachen was carried out between 1999 and 2010.
RESULTS: Of 614 patients admitted to the ICU because of acute GIB, 463 (75%) presented with upper GIB (UGIB) and 151 (25%) with lower GIB (LGIB). Despite early endoscopic intervention and ICU treatment, UGIB had a mortality rate of 16%, whereas LGIB showed a significantly better prognosis (mortality <5%) in the ICU setting. Risk factors for OGIB-related mortality were hemodynamic instability, organ failure, comorbidities (especially liver cirrhosis), and rebleeding. In total, 218 patients (36%) were treated with antiplatelet or anticoagulatory drugs, which were associated with a favorable prognosis in the UGIB group. Elevated serum lactate levels upon admission were superior in predicting mortality than established indicators of prognosis such as the Rockall or the Glasgow-Blatchford score.
CONCLUSIONS: Despite successful endoscopic intervention, severe acute UGIB is associated with a significant mortality rate of 16% in the ICU setting, determined by hemodynamic failure, organ dysfunction, and comorbidities. The serum lactate levels of patients with GIB on the day of admission to the ICU are prognostic.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23503668     DOI: 10.1007/s00063-013-0226-2

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  24 in total

1.  Clinical predictors of poor outcomes among patients with nonvariceal upper gastrointestinal bleeding in Europe.

Authors:  A Lanas; L Aabakken; J Fonseca; Z A Mungan; G V Papatheodoridis; H Piessevaux; L Cipolletta; J Nuevo; M Tafalla
Journal:  Aliment Pharmacol Ther       Date:  2011-04-11       Impact factor: 8.171

2.  Urgent endoscopy is associated with lower mortality in high-risk but not low-risk nonvariceal upper gastrointestinal bleeding.

Authors:  L G Lim; K Y Ho; Y H Chan; P L Teoh; C J Khor; L L Lim; A Rajnakova; T Z Ong; K G Yeoh
Journal:  Endoscopy       Date:  2011-02-28       Impact factor: 10.093

3.  Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study.

Authors:  G F Longstreth
Journal:  Am J Gastroenterol       Date:  1997-03       Impact factor: 10.864

4.  Prospective validation of the Rockall risk scoring system for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers.

Authors:  D S Sanders; M J Carter; R J Goodchap; S S Cross; D C Gleeson; A J Lobo
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

5.  Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding.

Authors:  Lisa L Strate; Yan L Liu; Edward S Huang; Edward L Giovannucci; Andrew T Chan
Journal:  Gastroenterology       Date:  2011-02-12       Impact factor: 22.682

6.  Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study.

Authors:  V Jairath; B C Kahan; R F A Logan; S A Hearnshaw; C J Doré; S P L Travis; M F Murphy; K R Palmer
Journal:  Endoscopy       Date:  2012-07-02       Impact factor: 10.093

7.  International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding.

Authors:  Alan N Barkun; Marc Bardou; Ernst J Kuipers; Joseph Sung; Richard H Hunt; Myriam Martel; Paul Sinclair
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

Review 8.  Epidemiology of acute upper gastrointestinal bleeding.

Authors:  M E van Leerdam
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

Review 9.  Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers.

Authors:  B Joseph Elmunzer; Scott D Young; John M Inadomi; Philip Schoenfeld; Loren Laine
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

10.  Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases.

Authors:  Joseph J Y Sung; Kelvin K F Tsoi; Terry K W Ma; Man-Yee Yung; James Y W Lau; Philip W Y Chiu
Journal:  Am J Gastroenterol       Date:  2009-09-15       Impact factor: 10.864

View more
  5 in total

1.  Do we still need pharmacological stress ulcer prophylaxis at the ICU?

Authors:  Lukas Buendgens; Frank Tacke
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 2.  [Direct oral anticoagulation and gastrointestinal bleeding: Interventional therapy management].

Authors:  G Braun; H Messmann; J Labenz; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-09-29       Impact factor: 0.840

Review 3.  [Gastrointestinal bleeding in cardiological patients].

Authors:  G Braun; H Messmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-10-24       Impact factor: 0.840

4.  Acute upper gastrointestinal bleeding: A stitch on time saves nine.

Authors:  Nishkarsh Gupta; Anju Gupta
Journal:  World J Gastrointest Endosc       Date:  2022-05-16

5.  Elevated lactate level predicts intensive care unit admissions, endoscopies and transfusions in patients with acute gastrointestinal bleeding.

Authors:  Manish P Shrestha; Mark Borgstrom; Eugene Abraham Trowers
Journal:  Clin Exp Gastroenterol       Date:  2018-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.